Cellosaurus logo
expasy logo

Cellosaurus Ff-I14s04 (CVCL_C1DM)

[Text version]
Cell line name Ff-I14s04
Synonyms Ff-I14 s04
Accession CVCL_C1DM
Resource Identification Initiative To cite this cell line use: Ff-I14s04 (RRID:CVCL_C1DM)
Comments Part of: Japanese HLA-homozygous iPS cell line panel.
From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
Population: Japanese.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
HLA typing Source: PubMed=35755947
Class I
HLA-AA*24:02
HLA-BB*52:01
Class II
HLA-DRDRB1*15:02
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_C1FD (Ff-I14s04 ABII KO #13)CVCL_C1FE (Ff-I14s04 ABII KO #14)CVCL_C1FF (Ff-I14s04 ABII KO #15)
CVCL_C1FG (Ff-I14s04 ABII KO #16)CVCL_C1FH (Ff-I14s04 ABII KO #18)CVCL_C1F9 (Ff-I14s04 ABII KO #2)
CVCL_C1FI (Ff-I14s04 ABII KO #22)CVCL_C1FJ (Ff-I14s04 ABII KO #24)CVCL_C1FA (Ff-I14s04 ABII KO #6)
CVCL_C1FB (Ff-I14s04 ABII KO #7)CVCL_C1FC (Ff-I14s04 ABII KO #8)
Originate from same individual CVCL_C1DX ! Ff-I01s01
CVCL_C1DY ! Ff-I01s04
CVCL_C1DZ ! Ff-I14s03
CVCL_C1E0 ! QHJI01s01
CVCL_C1E1 ! QHJI01s04
CVCL_C1E2 ! QHJI14s03
CVCL_C1DN ! QHJI14s04
Sex of cell Male
Age at sampling Age unspecified
Category Induced pluripotent stem cell
Publications

PubMed=31497180; DOI=10.1186/s41232-019-0106-0; PMCID=PMC6717959
Umekage M., Sato Y., Takasu N.
Overview: an iPS cell stock at CiRA.
Inflamm. Regen. 39:17.1-17.5(2019)

PubMed=35304548; DOI=10.1038/s41598-022-08753-5; PMCID=PMC8933508
Hiyoshi H., Sakuma K., Tsubooka-Yamazoe N., Asano S., Mochida T., Yamaura J., Konagaya S., Fujii R., Matsumoto H., Ito R., Toyoda T.
Characterization and reduction of non-endocrine cells accompanying islet-like endocrine cells differentiated from human iPSC.
Sci. Rep. 12:4740-4740(2022)

PubMed=35755947; DOI=10.1016/j.omtm.2022.05.010; PMCID=PMC9198376
Kitano Y., Nishimura S., Kato T.M., Ueda A., Takigawa K., Umekage M., Nomura M., Kawakami A., Ogawa H., Xu H.-G., Hotta A., Takasu N., Tsukahara M.
Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application.
Mol. Ther. Methods Clin. Dev. 26:15-25(2022)

PubMed=36395757; DOI=10.1016/j.medj.2022.10.003
Yoshida S., Kato T.M., Sato Y., Umekage M., Ichisaka T., Tsukahara M., Takasu N., Yamanaka S.
A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population.
Med 4:51-66.e10(2023)

Cross-references
Encyclopedic resources Wikidata; Q114311399
Entry history
Entry creation22-Sep-2022
Last entry update02-May-2024
Version number5